Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP) : a study protocol
MetadataShow full item record
Adam , R , Kanakarajan , S , Onyeakazi , U , Columb , M & Galley , H 2020 , ' Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP) : a study protocol ' , BMJ Open , vol. 10 , no. 3 , e034443 . https://doi.org/10.1136/bmjopen-2019-034443
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.